Clinical Trials on Prostate Cancer Castration-resistant Prostate Cancer in Switzerland
Total 98 results
-
MedImmune LLCCompletedMetastatic Castration Resistant Prostate CancerUnited States, Switzerland, United Kingdom
-
Innocrin PharmaceuticalCompletedCastration-resistant Prostate Cancer | CRPCUnited States, Greece, Switzerland, United Kingdom
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingMetastatic Castration-resistant Prostate CancerSwitzerland
-
Institute of Cancer Research, United KingdomAstraZeneca; Astellas Pharma Inc; Prostate Cancer UKTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom, Switzerland
-
University Hospital, Basel, SwitzerlandNot yet recruitingCastration-resistant Prostate CancerSwitzerland
-
Institute of Cancer Research, United KingdomSun Pharmaceutical Industries LimitedTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom, Switzerland
-
Swiss Group for Clinical Cancer ResearchNot yet recruitingMetastatic Castration-resistant Prostate CancerSwitzerland
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
Astellas Pharma Europe Ltd.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration Resistant Prostate CancerBelgium, France, Spain, Austria, Czechia, Germany, Greece, Italy, Netherlands, Norway, Poland, Russian Federation, Sweden, Switzerland, Turkey, United Kingdom
-
Hoffmann-La RocheTerminatedCastration-Resistant Prostatic CancerSpain, France, Switzerland, Italy
-
Kantonsspital GraubündenJanssen-Cilag Ltd.CompletedMetastatic Prostate CancerSwitzerland
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostatic Adenocarcinoma | Castration Levels of TestosteroneUnited States, Switzerland, Mexico, Chile, Colombia
-
University Hospital, GenevaUniversity of Zurich; Humanitas Hospital, Italy; Kantonsspital GraubündenRecruitingProstate CancerSwitzerland
-
University of ZurichUniversity College, LondonUnknown
-
Andrea AlimontiClinical Trial Unit Ente Ospedaliero CantonaleRecruitingProstate CancerSwitzerland
-
Kantonsspital GraubuendenSwiss Group for Clinical Cancer ResearchCompletedProstate Cancer | Prostate Cancer Recurrent | Lymph Node MetastasesSwitzerland
-
Irene BurgerCompletedProstate CancerSwitzerland
-
Oncology Institute of Southern SwitzerlandWithdrawn
-
Kantonsspital Winterthur KSWCompletedProstate CancerSwitzerland
-
Dominik AbtCompletedProstate CancerSwitzerland
-
Aurelius OmlinUniversity Hospital, Basel, Switzerland; Cantonal Hospital of St. GallenTerminated
-
ABX advanced biochemical compounds GmbHActive, not recruitingProstate Cancer | Prostate Cancer RecurrentUnited States, Netherlands, Switzerland
-
Swiss Group for Clinical Cancer ResearchTerminatedProstate Cancer | Cancer of the ProstateSwitzerland
-
BayerTerminated
-
Swiss Group for Clinical Cancer ResearchWithdrawnProstate CancerSwitzerland
-
University of Lausanne HospitalsAdvanced Accelerator ApplicationsCompleted
-
University of Lausanne HospitalsCompletedProstate CancerSwitzerland
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Swiss Group for Clinical Cancer ResearchCompletedProstate CancerSwitzerland
-
Oncology Institute of Southern SwitzerlandRecruiting
-
Swiss Group for Clinical Cancer ResearchTerminated
-
Life Molecular Imaging SACompleted
-
Swiss Group for Clinical Cancer ResearchCompletedProstate CancerSwitzerland
-
Swiss Group for Clinical Cancer ResearchTerminatedProstate Cancer | Prostate Cancer MetastaticFrance, Switzerland, Spain, Italy
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Zurich University of Applied SciencesCompleted
-
University of ZurichUnknownComprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic SignificanceProstate CancerSwitzerland
-
Novartis PharmaceuticalsRecruitingOligometastatic Prostate Cancer (OMPC)Japan, Singapore, Canada, Israel, Switzerland, Australia, United States
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Oncology Institute of Southern SwitzerlandRecruitingProstate CancerSwitzerland
-
University Hospital, Basel, SwitzerlandIntuitive SurgicalCompleted
-
University Hospital, Basel, SwitzerlandCompleted
-
Med Discovery SASoladis; Camara and Partners SàrlRecruiting
-
University of ZurichRecruiting
-
GlaxoSmithKlineCompletedNeoplasms, ProstateUnited States, Australia, France, Germany, Spain, Bulgaria, Estonia, Italy, Poland, Netherlands, Belgium, United Kingdom, Canada, Denmark, Ukraine, Finland, Latvia, Russian Federation, Greece, Slovenia, Brazil, Mexico, Slovakia, Japan, Puerto... and more
-
Swiss Group for Clinical Cancer ResearchCompletedProstate CancerSwitzerland
-
University GhentUniversity Hospital, GenevaActive, not recruitingProstate Cancer | Metastatic Cancer | Prostate Cancer Metastatic | Oligometastatic CancerNorway, Spain, Belgium, Switzerland, Australia, Italy
-
University of BaselWithdrawn
-
University Hospital, Basel, SwitzerlandDepartment of Urology, University Hospital Freiburg, Freiburg, Germany; Department...CompletedProstate Cancer | Localized CarcinomaSwitzerland
-
Ludwig Institute for Cancer ResearchCompletedProstate CancerSwitzerland, Germany